Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene

Donald Metcalf1, Marina R Carpinelli, Craig Hyland

  • 1Division of Cancer and Hematology, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia.

Blood
|January 25, 2005
PubMed

Insights

Mutations in the c-Myb gene cause excessive platelet production in mice, independent of thrombopoietin (TPO). This involves expanded megakaryocytopoiesis and altered progenitor cell responses to cytokines like GM-CSF.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Mice with c-Myb gene mutations (Plt3, Plt4) exhibit thrombopoietin (TPO)-independent thrombocytosis.
  • This condition is characterized by excessive megakaryocytopoiesis and impaired erythroid/lymphoid cell production.

Purpose of the Study:

  • To investigate the cellular mechanisms underlying thrombocytosis in c-Myb mutant mice.
  • To analyze megakaryocyte and progenitor cell production and characteristics.

Main Methods:

  • Analysis of megakaryocyte DNA ploidy and progenitor cell populations.
  • Assessment of progenitor cell responsiveness to granulocyte-macrophage colony-stimulating factor (GM-CSF).
  • Bone marrow transplantation studies in irradiated mice.

Main Results:

  • Thrombocytosis was not linked to altered platelet half-life.
  • Megakaryocytes showed reduced DNA ploidy, with an increase in mature precursors.
  • Mutant megakaryocyte progenitors displayed significantly enhanced GM-CSF responsiveness.
  • Mutant preprogenitor cells had limited capacity to form megakaryocyte progenitors.

Conclusions:

  • Altered c-Myb activity in hematopoietic stem cells skews differentiation towards megakaryocytopoiesis.
  • Enhanced progenitor cell sensitivity to cytokines like GM-CSF contributes to expanded megakaryocytopoiesis.
  • c-Myb mutations impact hematopoietic stem cell differentiation commitment, favoring megakaryocyte development.